Anti‐Tim‐3 and anti‐galectin‐9 antibodies block the interaction of galectin‐9/Tim‐3 resulting in a significant decrease in the suppression of Th1 cells induced by NPC EVs. Here, HAVCR2 is linked to nasopharyngeal carcinoma.